References
Reginster JY, Compston JE, Jones EA, et al. (1995) Recommendations for the registration of drugs used in the prevention and treatment of osteoporosis. Calcif Tissue Int 57:247–250
Miller SC, Bowman BM, Jee WS (1995) Available animal models of osteopenia—small and large. Bone 17:117S–123S
Compston JE (1994) Connectivity of cancellous bone: assessment and mechanical implications. Bone 15:463–466
Turner CH, Burr DB (1993) Basic biomechanical measurements of bone: a tutorial. Bone 14:595–608
Sambrook P, Birmingham J, Kempler S, et al. (1990) Corticosteroid-induced effects on proximal femur bone loss. J Bone Miner Res 5:1211–1216
Adinoff AD, Hollister JR (1983) Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309: 265–269
Hooyman JR, Melton LJ, Nelson AM, O’Fallon WM, Riggs BL (1984) Fractures after rheumatoid arthritis. A populationbased study. Arthritis Rheum 27:1353–1361
Aaron JE, Francis RM, Peacock M, Makins NB (1989) Contrasting microanatomy of idiopathic and corticosteroidinduced osteoporosis. Clin Orthop Rel Res 243:294–305
Chappard D, Legrand E, Basle MF, Fromont P, Audran M (1996) Altered trabecular architecture induced by corticosteroids. J Bone Miner Res 11:676–685
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Compston, J., Audran, M., Avouac, B. et al. Recommendations for the Registration of Agents Used in the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Calcif Tissue Int 59, 323–327 (1996). https://doi.org/10.1007/s002239900134
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s002239900134